SEC Form 4 · accession 0001232524-16-000214
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen L. Smith
Officer — Global Head of R&D and CMO
Period of report
Feb 25, 2016
Accepted (ET)
Feb 29, 2016 · 8:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Feb 25, 2016 | A | 6,000 | $0.00 | A | 13,143 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F3 | $123.36 | Feb 25, 2016 | A | 625 | A | — | Feb 24, 2026 | Ordinary Shares | 625 | 625 | D |
| Non-Qualified Stock Option (right to buy)F3 | $123.36 | Feb 25, 2016 | A | 14,375 | A | — | Feb 24, 2026 | Ordinary Shares | 14,375 | 14,375 | D |
Explanation of responses
- F1These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in four equal annual installments on the anniversary of the grant date, February 25, 2016.
- F2Includes 38 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2015.
- F3These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.